Human Rights on the Pharma Risk Management Agenda
Published: | Updated:
Milana Chamberlain and George Cameron ask: is it time for pharma to start using human rights language?
Milan Chamberlain and George Cameron
Advertisement
Milan Chamberlain is a Partner specialising in business and human rights and George Cameron is Of Counsel in the Life Sciences and Healthcare group at Norton Rose Fulbright.
Articles by Milan Chamberlain and George Cameron
Advertisement
Latest Updated Articles
Human Rights on the Pharma Risk Management AgendaPublished: November 3rd 2016 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Real-World Data Brings New Insights to Natural History of Disease Studies
2
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
5